Guardant Health, Inc.

GH M | $16.08 -3.54% -3.67% 1.9M

(0.0% 1d) (-8.6% 1m) (-33.4% 1y) (0.0% 2d) (0.0% 3d) (-10.6% 7d) (-27.21% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 1,957,140,602
http://www.guardanthealth.com
Sec Filling | Patents | 622 employees

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

cancer treatment

add to watch list Paper trade email alert is off

Press-releases

Multicancer Screening Market Projected to Reach $2.72 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-16 (Crawled : 03:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K

Health Services

| -3.59% | O: -1.53% H: 0.22% C: -1.13%
ILMN | $117.43 0.63% 0.63% 1.4M

Health Technology

| -7.43% | O: -6.72% H: 0.3% C: -1.27%
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -10.58% | O: -8.13% H: 0.3% C: -4.04%
report reach market

Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -21.16% | O: -0.14% H: 4.43% C: -5.11%
precision health meeting application

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -12.07% | O: -0.75% H: 4.38% C: 2.7%
test health cancer study

Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
Published: 2024-02-22 (Crawled : 00:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -27.67% | O: -0.04% H: 0.71% C: -1.68%
health year financial results

Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
Published: 2024-01-17 (Crawled : 14:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -30.4% | O: -2.21% H: 3.0% C: 2.48%
health asco cancer colon

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
Published: 2024-01-08 (Crawled : 09:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -36.42% | O: 2.99% H: 1.81% C: 1.36%
health genomic cancer africa

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -36.42% | O: 2.99% H: 1.81% C: 1.36%
health year results

Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
Published: 2024-01-02 (Crawled : 20:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -39.41% | O: -1.55% H: 2.85% C: -0.45%
health monroe

In Vitro Diagnostic Tests Market Report, with Profiles of 300+ Companies and Detail on the Top 40
Published: 2023-12-22 (Crawled : 00:00) - prnewswire.com
RNVA | $0.0001 0.0% 140M

Professional, Scientific, and T...

| -99.0% | O: 0.0% H: 0.0% C: 0.0%
TRIB | $1.81 -3.72% -3.87% 5.7K

Health Technology

| 307.98% | O: -6.87% H: 6.33% C: -3.57%
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -39.96% | O: 0.81% H: 5.38% C: 4.47%
CDNA | $8.32 3.1% 3.0% 500K

Health Technology

| -32.85% | O: -0.17% H: 4.71% C: 2.4%
TECH | $62.12 -0.15% -0.14% 910K

Health Technology

| -19.29% | O: 0.85% H: 0.33% C: -1.1%
AXDX | $0.8201 6.51% 6.1% 38K

Health Technology

| -80.85% | O: 0.23% H: 3.32% C: 1.41%
companies diagnostic market

Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-20 (Crawled : 00:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -41.25% | O: -7.53% H: 6.01% C: -2.25%
conference health

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001576280-24-000094	4	2024-04-16	2024-04-15	Sell	M	249	8745
0001576280-24-000094	4	2024-04-16	2024-04-15	Buy	M	249	3247
0001576280-24-000092	4	2024-04-16	2024-04-15	Sell	M	7569	15137
0001576280-24-000092	4	2024-04-16	2024-04-15	Sell	F	2701	25665
0001576280-24-000092	4	2024-04-16	2024-04-15	Buy	M	7569	28366
0001576280-24-000092	4	2024-04-16	2024-04-15	Sell	F	1108	20797
0001576280-24-000090	4	2024-04-16	2024-04-15	Sell	M	68	1232
0001576280-24-000090	4	2024-04-16	2024-04-15	Buy	M	68	7582
0001576280-24-000088	4	2024-04-05	2024-04-04	Sell	M	67	1062
0001576280-24-000088	4	2024-04-05	2024-04-04	Buy	M	67	4588
0001576280-24-000065	4	2024-03-19	2024-03-18	Buy	P	2187	12722